NUVARING VAGINAL RING
FDA nonproprietary name: etonogestrel and ethinyl estradiol
For 1 insert
Pharmacies pay
$155.70 filed
1 × $155.70283 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$184.06 estimated
$155.70 + $23.36 (15%) + $5.00 fee per fill = $184.06
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-07-22 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
NUVARING VAGINAL RING is how the CMS NADAC file names this product. The FDA NDC Directory lists it as etonogestrel and ethinyl estradiol, under the trade name “NuvaRing”.
FDA gives its dosage form as insert, extended release and its route as vaginal.
The labeler, the company named on the label, is Organon LLC.
FDA lists it under 2 Established Pharmacologic Classes: Estrogen and Progestin.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes); the FDA directory lists 1 of them.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $155.70 for 1 insert (1 × $155.70283 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-07-22. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 4, carried forward from the previous file.
The NADAC of all 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-07-22. The file is new; the price is not.
NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $46.3541 per EA filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · NADAC explanation codes · Carried-forward prices
All 2 NDCs
- 78206-0146-01 · not listed as a package in the FDA directory · $155.70283 per EA · eff. 2026-07-22 filed carried forward
- 78206-0146-03 · Organon LLC · $155.70283 per EA · eff. 2026-07-22 filed carried forward
Other strengths, forms and brands
2 other products in the NADAC file share the FDA nonproprietary name etonogestrel and ethinyl estradiol with NUVARING VAGINAL RING.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ELURYNG VAGINAL RING | $46.3541 per EA filed | $75.7298 per EA filed |
| ETONOGESTREL-EE VAGINAL RING | $46.3541 per EA filed | We don’t know yet |
| NUVARING VAGINAL RING this page | $155.70283 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $155.70283 per EA filed.
Of the 104 other products in FDA’s Estrogen class priced per EA, 4 have a higher middle NADAC price and 100 a lower one. The one in the middle is LYLLANA 0.075 MG PATCH, at $8.11285 per EA filed (eff. 2026-09-23).
Of the 65 other products in FDA’s Progestin class priced per EA, 1 has a higher middle NADAC price and 64 a lower one. The one in the middle is NORETHIN-ETH ESTRAD 1 MG-5 MCG, at $0.57994 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 insert? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 1 insert?
- NADAC prices this product per EA, and the FDA NDC Directory lists 1 of its 2 NDCs (it does not list the other one) as dosage form “INSERT, EXTENDED RELEASE” with route “VAGINAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. So the card starts at 1 insert, priced per insert, rather than guess how many make up a fill; change it to match your prescription.
Related pages
Its pharmacologic classes
Related in the same class
- PREMPRO 0.3 MG-1.5 MG TABLET
- ABIGALE 1 MG-0.5 MG TABLET
- NORTREL 1-35 21 TABLET
- COMBIPATCH 0.05-0.14 MG PTCH
- CLIMARA PRO PATCH